期刊文献+

降钙素原和超敏C反应蛋白检测在慢性阻塞性肺疾病急性加重期的意义 被引量:9

Detection significance of serum procalcitonin and high-sensitivity C-reactive protein in acute exacerbation stage of chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨降钙素原和超敏C反应蛋白在慢性阻塞性肺疾病急性加重期中的检测效果及其意义。方法对来我院诊治的40例慢性阻塞性肺疾病急性加重期患者设为实验组,取40例非急性加重期慢性阻塞性肺疾病患者为对照组,比较两组PCT及hs-CRP水平。结果实验组治疗前PCT指标为(3.32±0.81)ng/m L、hs-CRP指标为(22.36±5.03)mg/L、WBC指标为(10.31±1.56)×109/L,均高于对照组(P<0.05);实验组PCT、hs-CRP阳性诊断率分别为67.5%和60%,均高于对照组(P<0.05)。结论慢性阻塞性肺疾病急性加重期采用PCT和hs-CRP联合诊断具有重要的临床价值,值得推广使用。 Objective To study the detection effect and significance serum procalcitonin(PCT)and high-sensitivity C-reactive protein(hs-CRP)in acute exacerbation stage of chronic obstructive pulmonary disease. Methods 40 cases with chronic obstructive pulmonary disease in acute exacerbation stage who were treated in our hospital were selected as experimental group,while 40 cases in non-acute exacerbation stage were selected as control group.To compare the level of PCT and hs-CRP between the two groups. Results PCT(3.32±0.81)ng/mL,hs-CRP(22.36±5.03)mg/L,WBC(10.31±1.56)×109/L before treatment in experimental group were higher than which in control group,the differences all had statistical significance(P〈0.05).The positive diagnostic rate of PCT(67.5%)and hs-CRP(60%)in experimental group were higher than which in control group,the differences all had statistical significance(P〈0.05). Conclusion Detection of PCT combined hs-CRP in acute exacerbation stage of chronic obstructive pulmonary disease has significant clinical value and is worthy of popularization and application.
作者 朱秋蕾
出处 《中国医药科学》 2015年第8期151-152,158,共3页 China Medicine And Pharmacy
关键词 降钙素原 超敏C反应蛋白 慢性阻塞性肺疾病急性加重期 PCT hs-CRP Acute exacerbation stage of chronic obstructive pulmonary disease
  • 相关文献

参考文献13

二级参考文献110

共引文献4077

同被引文献77

  • 1孟广平,辛秀琴,张捷,许溟宇.探讨AECOPD患者血清中SP-D及CRP水平变化与肺功能的关系[J].中国实用内科杂志,2013,33(S1):53-54. 被引量:2
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3慢性阻塞性肺疾病急性加重患者机械通气指南(2007)[J].中华急诊医学杂志,2007,16(4):350-357. 被引量:244
  • 4Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary diseasein China:a large,populationbased survey[J].Am J Respir Cfit Care Med,2007(176):753-760.
  • 5Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESKM/ACCP/ATS/SIS international Sepsis Definitions Conference[J].Crit Care Med,2003(1):250-256.
  • 6Verduri A,Luppi F, D'Amico R,et a/.Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin:a randomized noninferiority tri- al[J].PLoS One,2015,10(3) :e0118241.
  • 7Grolimund E, Kutz A, Marlowe RJ,et a/.Long-term progno- sis in COPD exacerbation:role of biomarkers,clinical vari- ables and exacerbation type [J].COPD, 2015,12 (3) : 295 -305.
  • 8Sridharan P,Chamberlain RS.The efficacy of procalcitonin as a biomarker in the management of sepsis:slaying dragons or tilting at windmills?[J].Surg Infect(Larchmt),2013,14(6):489-511.
  • 9Iwamoto T,Terai S,Mizunaga Y,et al.Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients[J].J Gastroenterol,2012,47(3):300-312.
  • 10O′Grady KA,Torzillo PJ,Ruben AR,et al.Identification of radiological alveolar pneumonia in children with high rates of hospitalized respiratory infections:comparison of WHO-defined and pediatric pulmonologist diagnosis in the clinical context[J].Pediatr Pulmonol,2012,47(4):386-392.

引证文献9

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部